DOTA-TATE acetate is a DOTA-chelated somatostatin analog peptide (DOTA‑(Tyr³)-octreotate) used as a precursor for radiolabeling in PET imaging and peptide receptor radionuclide therapy targeting somatostatin receptor–positive tumors, especially neuroendocrine tumors. The directory classifies it as a clinical API with a peptide source/manufacturing origin. Other names for this substance include DOTA-TATE acetate and UNII-99R86Y6V0M. Its PubChem CID is 131634410.
Oxodotreotide acetate
| CAS No | 177943-89-4 |
|---|---|
| Molecular Formula | C73H106N14O27S2 |
| Molecular Weight | 1675.8 g/mol |
| Synonyms | acetic acid;(2S,3R)-2-[[(4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-7-[(1R)-1-hydroxyethyl]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-[[(2R)-3-phenyl-2-[[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetyl]amino]propanoyl]amino]-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]amino]-3-hydroxybutanoic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
DOTA-TATE acetate is a DOTA-chelated somatostatin analog peptide (DOTA‑(Tyr³)-octreotate) used as a precursor for radiolabeling in PET imaging and peptide receptor radionuclide therapy targeting somatostatin receptor–positive tumors, especially neuroendocrine tumors.
The listed CAS number is 177943-89-4.
The listed molecular formula is C73H106N14O27S2.
The listed molecular weight is 1675.8 g/mol.
acetic acid;(2S,3R)-2-[[(4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-7-[(1R)-1-hydroxyethyl]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-[[(2R)-3-phenyl-2-[[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetyl]amino]propanoyl]amino]-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]amino]-3-hydroxybutanoic acid.
The source lists DOTA-TATE acetate and UNII-99R86Y6V0M.